Revolutionizing Breast and Axillary Biopsies: NeoDynamics’ NEONAVIA Now Available in the US!

NeoDynamics, Inc., a pioneering MedTech company, is proud to announce the U.S. availability of NEONAVIA – a revolutionary biopsy system utilizing patented pulse technology that enables precise needle insertion and control, giving patients a more accurate diagnosis and better care for breast cancer.

Today, NEONAVIA is making its commercial debut at two of the most prestigious medical events in the US: The American Society of Breast Surgeons (ASBrS) 24th Annual Meeting at the John B. Hynes Veterans Memorial Convention Center in Boston, Massachusetts, and the SBI Breast Imaging Symposium, May 4-7, 2023, at the Gaylord National Resort & Convention Center in National Harbor, Maryland.

ASBrS is the primary leadership organization for general surgeons who treat patients with breast disease and has over 3000 members in the US and 35 countries around the world. SBI is the leading network of breast radiologists and medical physicists in the U.S. and is a great platform for NEONAVIA to showcase its innovative technology.

Unlock the power of pulse technology with NeoDynamics’ NEONAVIA system! Our commercial team will be offering interactive workshops and demos to showcase the precision and control it has to offer, as well as its FlexiPulse retractable, open-tip needle which can bring up to a whopping 299% larger sample* than side-notch core needle systems. Experience the potential of NEONAVIA today!

We are eager to join the conversations at these important events that are devoted to improving breast care with early detection, diagnosis, and treatment. Our precision pulse biopsy innovation is a targeted approach to lesion insertion and tissue sampling, which is key to providing accurate cancer diagnosis, personalised treatment plans, and improved patient comfort. We look forward to connecting with the influential players in the field and contributing to the progress of breast care.

NEONAVIA’s PULSE study has been accepted for electronic presentation at the 2023 SBI Breast Imaging Symposium. This groundbreaking, multi-center trial evaluates the use of ultrasound-guided lymph node biopsy with NEONAVIA and will be available for on-demand viewing for attendees, as well as featured in the interactive e-Poster Gallery on the SBI Symposium website. Don’t miss this chance to learn more about this innovative research and its potential to revolutionize breast imaging.

Leave a Comment